New sleep pill shows promise for teen insomnia in early trial
Symptom relief
Completed
This study tested daridorexant, a sleep medication, in 166 teenagers aged 10 to 17 with chronic insomnia. Participants took one of three doses of the drug or a placebo each evening. Researchers measured changes in total sleep time using overnight sleep tests and monitored safety.…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC